Clinical Scorecard: Exploring the Connection Between Subacute Thyroiditis and Viral Infections

At a Glance

Key Highlights

• SAT shows seasonal peak in late summer coinciding with enterovirus circulation but no causal association established
• Strong association with HLA-B*35 and other HLA alleles; females more frequently affected
• COVID-19 pandemic hygiene measures reduced many viral infections but did not alter SAT incidence or seasonality

Guideline-Based Recommendations

Diagnosis

• Clinical diagnosis based on painful thyroid swelling, migratory pain, and symptoms of thyrotoxicosis followed by hypothyroidism
• Consider history of preceding respiratory symptoms in approximately 23% of cases
• No specific autoantibody profile diagnostic; transient antithyroglobulin and antithyroid peroxidase antibodies may be present

Management

• Symptomatic treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and systemic corticosteroids during acute phase
• Note that corticosteroids may alleviate symptoms but do not influence risk of permanent hypothyroidism
• Monitor thyroid function over time as full recovery occurs in about 75% of patients

Monitoring & Follow-up

• Follow thyroid hormone levels to detect transition from thyrotoxicosis to hypothyroidism
• Monitor for resolution of symptoms and normalization of thyroid function
• Assess for development of permanent hypothyroidism requiring long-term management

Risks

• Potential progression to permanent hypothyroidism in approximately 25% of cases
• Symptomatic complications such as fever, malaise, and rare tracheal compression causing dry cough

Patient & Prescribing Data

Patients diagnosed with subacute thyroiditis, predominantly females in middle age

NSAIDs and corticosteroids are commonly prescribed to relieve acute symptoms; no evidence that treatment alters long-term thyroid outcomes

Clinical Best Practices

• Recognize seasonal pattern but do not rely on viral infection presence for diagnosis
• Use corticosteroids judiciously for symptom control without expectation of altering disease course
• Educate patients about the typical disease course including transient thyrotoxicosis and possible hypothyroidism
• Consider HLA typing in research settings but not routinely for clinical management
• Remain vigilant for rare cases linked temporally to vaccinations or SARS-CoV-2 infection but understand causality is unproven

References

• Incidence and clinical features of subacute thyroiditis
• Seasonality and viral hypotheses in subacute thyroiditis
• Impact of COVID-19 pandemic on infectious diseases and SAT incidence